Maximum Targeted Ablation of Atrial Flutter

This study is currently recruiting participants.

Verified by Lawson Health Research Institute, June 2007

Sponsored by:	Lawson Health Research Institute
Information provided by:	Lawson Health Research Institute
ClinicalTrials.gov Identifier:	NCT00491010

Purpose

Patients undergoing atrial flutter ablation will be randomized to either the standard ablation approach or voltage targeted approach. Patients will be followed for one year to assess outcome of the ablation technique

Condition	Intervention	Phase
Atrial Flutter	Procedure: radiofrequency catheter ablation	Phase IV

Genetics Home Reference related topics: Brugada syndrome short QT syndrome

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title:	Maximum Targeted Ablation of Atrial Flutter

Further study details as provided by Lawson Health Research Institute:

Study Start Date:	July 2006
Estimated Study Completion Date:	February 2008

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

patients undergoing TV-IVC isthmus ablatin for atrial flutter

Exclusion Criteria:

atypical atrial flutter
<18 years old any atrial surgery or pacemaker refusal to participate

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00491010

Contacts

Contact: Allan Skanes, MD	519-685-8500 ext 32739	askanes@uwo.ca
Contact: Lorne gula, MD	519 685-8500 ext 32739	lgula@uwo.ca

Locations

Canada, Ontario
London Health Sciences Center	Recruiting
London, Ontario, Canada, N6A 5A5
Sub-Investigator: Lorne Gula, MD

Sponsors and Collaborators

Lawson Health Research Institute

Investigators

Principal Investigator:

Allan c Skanes, MD

University of Western Ontario, London Health Sciences Center

More Information

Study ID Numbers:	R-06-153, 12266
Study First Received:	June 21, 2007
Last Updated:	June 21, 2007
ClinicalTrials.gov Identifier:	NCT00491010
Health Authority:	Canada: Ethics Review Committee

Keywords provided by Lawson Health Research Institute:

atrial flutter
ablation
voltage targeted

Study placed in the following topic categories:

Heart Diseases
Atrial Flutter
Arrhythmias, Cardiac

Additional relevant MeSH terms:

Pathologic Processes
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 14, 2009